Romy Roy

Mr. Romy Roy

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
Mufeeda Chemban KoyilotMufeeda Chemban Koyilot
Mufeeda Chemban Koyilot
PNPriya darshini Natarajan
Priya darshini Natarajan
CHClayton R. Hunt
Clayton R. Hunt
SSSonish Sivarajkumar
Sonish Sivarajkumar
RRRomy Roy
Romy Roy
KYKamlesh K Yadav
Kamlesh K Yadav
Organ-on-a-chip (OOAC) is an emerging technology based on microfluid platforms and in vitro cell culture that has a promising future in the healthcare industry. The numerous advantages of OOAC over conventional systems make it highly popular. The chip is an innovative combination of novel technologies, including lab-on-a-chip, microfluidics, biomaterials, and tissue engineering. This paper begins by analyzing the need for the development of OOAC followed by a brief introduction to the technology. Later sections discuss and review the various types of OOACs and the fabrication materials used. The implementation of artificial intelligence in the system makes it more advanced, thereby helping to provide a more accurate diagnosis as well as convenient data management. We introduce selected OOAC projects, including applications to organ/disease modelling, pharmacology, personalized medicine, and dentistry. Finally, we point out certain challenges that need to be surmounted in order to further develop and upgrade the current systems.

1 April 2022 in Recent Advances in Food, Nutrition & Agriculture
Verified
Journal Article
Open access
PDF file
RRRomy Roy
Romy Roy
SMShamsudheen Marakkar
Shamsudheen Marakkar
MVMunawar Peringadi Vayalil
Munawar Peringadi Vayalil
ASAlisha Shahanaz
Alisha Shahanaz
AAAthira P Anil
Athira P Anil
KYKamlesh Yadav
Kamlesh Yadav
The drug-food interaction brings forth changes in the clinical effects of drugs. While favourable interactions bring positive clinical outcomes, unfavourable interactions may lead to toxicity. This article reviews the impact of food intake on drug-food interactions, the clinical effects of drugs, and the effect of drug-food in correlation with diet and precision medicine. Emerging areas in drug-food interactions are the food–genome interface (nutrigenomics) and nutrigenetics. Understanding the molecular basis of food ingredients, including genomic sequencing and pharmacological implications of food molecules, help to reduce the impact of drug-food interactions. Various strategies are being leveraged to alleviate drug-food interactions: measures including patient engagement, digital health, approaches involving machine intelligence, and big data are a few of them. Furthermore, delineating the molecular communications across diet-microbiome-drug-food-drug interactions in a pharmacomicrobiome framework may also play a vital role in personalized nutrition. Determining nutrient-gene interactions aids in making nutrition deeply personalized and helps mitigate unwanted drug-food interactions, chronic diseases, and adverse events from its onset. Translational bioinformatics approaches could play an essential role in the next generation of drug-food interaction research. In this landscape review, we discuss important tools, databases, and approaches along with key challenges and opportunities in drug-food interaction and its immediate impact on precision medicine.